Addressing Asia’s high cancer incidence

WINTHER: The WIN therapeutics clinical trial

The involvement of rare cancer patients in clinical research

Introduction of PET tracers to the WINTHER trial

Application of next generation sequencing

Next generation sequencing and WIN therapeutics

Identifying targets with systems medicine

Importance of early detection and the ‘Beyond the Shock’ programme

Shortening the timeline for clinical drug developments

Building international collaborations and the WINTHER trial

Addressing the problem of adherence to treatment

Patient and doctor communication and quality of life guidelines